Teleconference Topic Will Be Cellular Therapy
for Tissue Repair and Stem Cell Transplant

“Cellular Therapy for Tissue Repair and Stem Cell Transplantation” is the topic of a 90-minute teleconference developed by ASBMT for transmission across the country on April 26.  Designed for physicians, technologists, residents/fellows, nurses and managers/supervisions, the teleconference is part of a series sponsored by the AABB.

Several dimensions of cellular therapy for tissue repair will be explored:

• How to design and operate a GMP facility that complies with institutional, FDA and NIH regulations
• An update on studies using genetically manipulated T-cells for the control of graft-versus-host disease (GvHD) in allogeneic stem cell transplantation.
• Progress in the expansion of umbilical cord blood stem cells to enhance engraftment after allogeneic stem cell transplantation.

The faculty will be Drs. Robert Negrin of Stanford University, E. J. Shpall of M.D. Anderson Cancer Center, and John DiPersio, Jan Nolta and Gerhard Bauer, all of Siteman Cancer Center at Washington University School of Medicine.

For information or to enroll in this and other teleconferences in the series, visit the AABB Web site.

Topics of other upcoming teleconferences include:

April 5 – “Tool Time!”
April 12 – Reimbursement for Blood Products and Services
April 26 – Cellular Therapy for Tissue Repair and Stem Cell Transplantation
May 3 – Adverse Transfusion-Associated Events
May 10 – Transfusion-Transmitted Diseases:  vCJD, Chagas’ Disease and Other Emergent Pathogens
May 17 – Enfermedades Transmitidas por Transfusion:  Variante de CJD, Enfermedad de Chagas, y Otros Patogenos Emergentes
May 24 – Multi-Component Collections
June 7 – Reporting and Cell Therapy Facilities
June 21 – Therapeutic Apheresis
July 12 – Redefining DLI – Targeting Cellular Therapies
July 26 – Benchmarking
Aug. 9 – Transfusion When Nothing is Compatible:  Evaluating and Managing Risk
Aug. 23 – Blood Conservation
Sept. 13 – Non-Hematopoietic Uses for Hematopoietic Progenitor Cells
Sept. 27 – Donor Deferrals:  The Past, The Present, The Future?
Oct. 24 – Communication Crisis
Oct. 11 – Transfusion Triggers:  Formulating Transfusion Strategies that Optimize Patient Care
Nov. 1 – I.T. Systems Selection and Validation
Nov. 15 – ISBT 128: Making the Transition
Dec. 6 – Peak Performance
Dec. 13 – Legal Issues in Clinical Education